Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug-Reference-Cited by-同舟云学术

Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug

Published:2015-12 Issue:12 Volume:35 Page:1164-1172
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Verlinden Nathan J.¹,Coons James C.²³

Affiliation:

1. Department of Pharmacy; Allegheny General Hospital; Pittsburgh Pennsylvania

2. Department of Pharmacy; UPMC Presbyterian University Hospital; Pittsburgh Pennsylvania

3. University of Pittsburgh School of Pharmacy; Pittsburgh Pennsylvania

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1664/fullpdf

Reference50 articles.

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults;Maron;Circulation,1995

2. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Gersh;Circulation,2011

3. Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy;Landstrom;Circulation,2010

4. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives;Maron;J Am Coll Cardiol,2012

5. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance;Maron;J Am Coll Cardiol,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Frontiers in Hypertrophic Obstructive Cardiomyopathy;Journal of Cardiothoracic and Vascular Anesthesia;2024-09

2. HCM-associated mutations in MYH6/7 drive pathologic expression of TGF-β1 in cardiomyocytes within weeks of developmental specification;2024-08-09

3. An overview of the treatments for hypertrophic cardiomyopathy;Frontiers in Cardiovascular Medicine;2024-06-03

4. Spezielle medikamentöse und interventionelle Therapieverfahren der hypertrophen Kardiomyopathie;Aktuelle Kardiologie;2024-05-29

5. Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy;JACC: Advances;2023-10